Lexagene Holdings (Lexagene Holdings) Days Sales Outstanding : 81.70 (As of Nov. 2022)

View and export this data going back to 2017. Start your Free Trial

What is Lexagene Holdings Days Sales Outstanding?

Lexagene Holdings's average Accounts Receivable for the three months ended in Nov. 2022 was $0.04 Mil. Lexagene Holdings's Revenue for the three months ended in Nov. 2022 was $0.04 Mil. Hence, Lexagene Holdings's Days Sales Outstanding for the three months ended in Nov. 2022 was 81.70.

The historical rank and industry rank for Lexagene Holdings's Days Sales Outstanding or its related term are showing as below:

LXXGQ's Days Sales Outstanding is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 65.41
* Ranked among companies with meaningful Days Sales Outstanding only.

Lexagene Holdings's Days Sales Outstanding increased from Nov. 2021 (58.93) to Nov. 2022 (81.70).

Lexagene Holdings Days Sales Outstanding Historical Data

The historical data trend for Lexagene Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings Days Sales Outstanding Chart

Lexagene Holdings Annual Data

Trend

Mar13

Mar14

Mar15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Days Sales Outstanding

Get a 7-Day Free Trial

147.89

141.13

Lexagene Holdings Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
Days Sales Outstanding	Get a 7-Day Free Trial															58.93	-	118.63	37.40	81.70

Competitive Comparison of Lexagene Holdings's Days Sales Outstanding

For the Medical Devices subindustry, Lexagene Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lexagene Holdings's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's Days Sales Outstanding falls into.

Lexagene Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Lexagene Holdings's Days Sales Outstanding for the fiscal year that ended in Feb. 2022 is calculated as

	Days Sales Outstanding (A: Feb. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Feb. 2021 )	+	Accounts Receivable (A: Feb. 2022 ))	/	count )	/	Revenue (A: Feb. 2022 )	*	Days in Period
=	( (0.044	+	0.014)	/	2 )	/	0.075	*	365
=	0.029					/	0.075	*	365
=	141.13

Lexagene Holdings's Days Sales Outstanding for the quarter that ended in Nov. 2022 is calculated as:

	Days Sales Outstanding (Q: Nov. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Aug. 2022 )	+	Accounts Receivable (A: Nov. 2022 ))	/	count )	/	Revenue (A: Nov. 2022 )	*	Days in Period
=	( (0.025	+	0.052)	/	2 )	/	0.043	*	365 / 4
=	0.0385					/	0.043	*	365 / 4
=	81.70

Lexagene Holdings (OTCPK:LXXGQ) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Lexagene Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Lexagene Holdings (Lexagene Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (OTCPK:LXXGQ) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915

Website

https://www.lexagene.com

Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.